Clinical data revealed much higher RANKL and OPG protein levels in the serum of CN patients than in healthy controls, consistent with a high RANKL/OPG ratio among CN patients (Jansen et al., 2018). This evidence concerns the gene TNFRSF11B and cyclic hematopoiesis.